| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $2,741,013 ) |
| | 2024 | 2024 | GEISINGER CLINIC | 100 N ACADEMY AVE | DANVILLE | PA | 17822-9800 | MONTOUR | USA | R01HL148246 | Identification Methods, Patient Activation, and Cascade Testing for FH: IMPACT-FH | 000 | 5 | NIH | 1/30/2024 | $718,610 |
| | 2024 | 2024 | GEISINGER CLINIC | 100 N Academy Ave | Danville | PA | 17822-9800 | MONTOUR | USA | H7646012 | Ryan White Part C Outpatient EIS Program | 00 | 3 | HRSA | 3/6/2024 | $87,498 |
| | 2024 | 2024 | GEISINGER CLINIC | 100 N ACADEMY AVE | DANVILLE | PA | 17822-9800 | MONTOUR | USA | U01HL146188 | Collaborative Research to Explore Genetic Variation and Phenotypic Spectrum of Elastin and Related Genes | 000 | 5 | NIH | 2/27/2024 | $565,660 |
| | 2024 | 2024 | GEISINGER CLINIC | 100 N ACADEMY AVE | DANVILLE | PA | 17822-9800 | MONTOUR | USA | R33HL161775 | Collaborative Approach to Reach Everyone with Familial Hypercholesterolemia: CARE-FH | 001 | 3 | NIH | 2/24/2024 | $658,852 |
| | 2024 | 2024 | GEISINGER CLINIC | 100 N ACADEMY AVE | DANVILLE | PA | 17822-9800 | MONTOUR | USA | R01HL148246 | Identification Methods, Patient Activation, and Cascade Testing for FH: IMPACT-FH | 001 | 5 | NIH | 3/8/2024 | $0 |
| | 2024 | 2024 | GEISINGER CLINIC | 100 N ACADEMY AVE | DANVILLE | PA | 17822-9800 | MONTOUR | USA | R01MH074090 | Gene Dosage Imbalance in Neurodevelopmental Disorders | 000 | 18 | NIH | 1/5/2024 | $713,564 |
| | 2024 | 2023 | GEISINGER CLINIC | 100 N ACADEMY AVE | DANVILLE | PA | 17822-9800 | MONTOUR | USA | T6249313 | Integrated Substance Use Disorder (SUD) Training Program | 02 | 1 | HRSA | 10/12/2023 | $0 |
| | 2024 | 2023 | GEISINGER CLINIC | 100 N ACADEMY AVE | DANVILLE | PA | 17822-9800 | MONTOUR | USA | T6249313 | Integrated Substance Use Disorder (SUD) Training Program | 03 | 1 | HRSA | 11/25/2023 | $0 |
| | 2024 | 2023 | Geisinger Clinic | 100 N Academy Ave | Danville | PA | 17822-9800 | MONTOUR | USA | NU58DP007587 | The Innovative Cardiovascular Health Program | 02 | 1 | CDC | 3/8/2024 | $0 |
| | 2024 | 2023 | Geisinger Clinic | 100 N Academy Ave | Danville | PA | 17822-9800 | MONTOUR | USA | NU58DP007587 | The Innovative Cardiovascular Health Program | 01 | 1 | CDC | 1/30/2024 | $0 |
| | 2024 | 2023 | GEISINGER CLINIC | 100 N ACADEMY AVE | DANVILLE | PA | 17822-9800 | MONTOUR | USA | P1349602 | Rural Residency Planning and Development Program | 02 | 1 | HRSA | 10/4/2023 | $0 |
| | 2024 | 2023 | GEISINGER CLINIC | 100 N ACADEMY AVE # MC4970 | DANVILLE | PA | 17822-9800 | MONTOUR | USA | R33HL161775 | Collaborative Approach to Reach Everyone with Familial Hypercholesterolemia: CARE-FH | 000 | 2 | NIH | 12/11/2023 | $7,028 |
| | 2024 | 2023 | GEISINGER CLINIC | 100 N ACADEMY AVE | DANVILLE | PA | 17822-9800 | MONTOUR | USA | H79TI084778 | Free2BMom | 001 | 2 | SAMHSA | 10/30/2023 | $0 |
| | 2024 | 2023 | GEISINGER CLINIC | 100 N ACADEMY AVE | DANVILLE | PA | 17822-9800 | MONTOUR | USA | H79TI084778 | Free2BMom | 002 | 2 | SAMHSA | 11/16/2023 | $0 |
| | 2024 | 2023 | GEISINGER CLINIC | 100 N ACADEMY AVE | DANVILLE | PA | 17822-9800 | MONTOUR | USA | H7646012 | Ryan White Part C Outpatient EIS Program | 01 | 2 | HRSA | 12/8/2023 | $0 |
| | 2024 | 2023 | GEISINGER CLINIC | 100 N ACADEMY AVE | DANVILLE | PA | 17822-9800 | MONTOUR | USA | H2A39958 | Telehealth Network Grant Program | 01 | 4 | HRSA | 1/31/2024 | $0 |
| | 2024 | 2023 | GEISINGER CLINIC | 100 N ACADEMY AVE # MC4970 | DANVILLE | PA | 17822-9800 | MONTOUR | USA | D5837570 | Residency Training in Primary Care | 03 | 4 | HRSA | 4/16/2024 | $0 |
| | 2024 | 2023 | GEISINGER CLINIC | 100 N ACADEMY AVE | DANVILLE | PA | 17822-9800 | MONTOUR | USA | D5837570 | Residency Training in Primary Care | 02 | 4 | HRSA | 1/18/2024 | $0 |
| | 2024 | 2023 | GEISINGER CLINIC | 100 N ACADEMY AVE | DANVILLE | PA | 17822-9800 | MONTOUR | USA | U01CA240747 | Feasibility and Assessment of a Cascade Traceback Screening program - FACTS | 001 | 4 | NIH | 2/12/2024 | $0 |
| | 2024 | 2023 | GEISINGER CLINIC | 100 N ACADEMY AVE | DANVILLE | PA | 17822-9800 | MONTOUR | USA | U01CA240747 | Feasibility and Assessment of a Cascade Traceback Screening program - FACTS | 000 | 4 | NIH | 12/21/2023 | $0 |
| | 2024 | 2022 | GEISINGER CLINIC | 100 N ACADEMY AVE | DANVILLE | PA | 17822-9800 | MONTOUR | USA | H79TI084778 | Free2BMom | 000 | 1 | SAMHSA | 10/27/2023 | $0 |
| | 2024 | 2022 | GEISINGER CLINIC | 100 N ACADEMY AVE # MC4970 | DANVILLE | PA | 17822-9800 | MONTOUR | USA | R61HL161775 | Collaborative Approach to Reach Everyone with Familial Hypercholesterolemia: CARE-FH | 000 | 1 | NIH | 12/11/2023 | -$7,028 |
| | 2024 | 2022 | GEISINGER CLINIC | 100 N Academy Ave | Danville | PA | 17822-9800 | MONTOUR | USA | NU58DP006962 | Supplemental Funding to Support COVID-19 and Influenza Vaccine in Cambiamos and Scranton | 03 | 2 | CDC | 10/26/2023 | $0 |
| | 2024 | 2022 | Geisinger Clinic | 100 N Academy Ave | Danville | PA | 17822-9800 | MONTOUR | USA | NU58DP006962 | Supplemental Funding to Support COVID-19 and Influenza Vaccine in Cambiamos and Scranton | 02 | 2 | CDC | 10/17/2023 | $0 |
| | 2024 | 2021 | GEISINGER CLINIC | 100 N Academy Ave | Danville | PA | 17822-9800 | MONTOUR | USA | NU58DP006962 | Supplemental Funding to Support COVID-19 and Influenza Vaccine in Cambiamos and Scranton | 03 | 2 | CDC | 10/26/2023 | $0 |
| | 2024 | 2021 | Geisinger Clinic | 100 N Academy Ave | Danville | PA | 17822-9800 | MONTOUR | USA | NU58DP006962 | Supplemental Funding to Support COVID-19 and Influenza Vaccine in Cambiamos and Scranton | 02 | 2 | CDC | 10/17/2023 | $0 |
| | 2024 | 2021 | GEISINGER CLINIC | 100 N ACADEMY AVE | DANVILLE | PA | 17822-9800 | MONTOUR | USA | R01DA044015 | Clinical and Genetic Study of Prescription Opioid Addiction | 000 | 5 | NIH | 11/1/2023 | $0 |
| | 2024 | 2021 | GEISINGER CLINIC | 100 N ACADEMY AVE # MC4970 | DANVILLE | PA | 17822-9800 | MONTOUR | USA | R01CA211723 | Implementing Universal Lynch Syndrome Screening across Multiple Healthcare Systems: Identifying Strategies to Facilitate and Maintain Programs in Different Organizational Contexts | 000 | 5 | NIH | 3/1/2024 | -$3,172 |
|
| Issue Date FY: 2023 ( Subtotal = $13,999,128 ) (Continued on the next page) |
| | 2023 | 2023 | GEISINGER CLINIC | 100 N ACADEMY AVE | DANVILLE | PA | 17822-9800 | MONTOUR | USA | R01MH074090 | Gene Dosage Imbalance in Neurodevelopmental Disorders | 000 | 17 | NIH | 1/20/2023 | $791,368 |
| | 2023 | 2023 | GEISINGER CLINIC | 100 N Academy Ave | Danville | PA | 17822-9800 | MONTOUR | USA | U18DP006509 | Electronic Health Record-based Surveillance of Diabetes by Type in Young Adults in Pennsylvania | 00 | 4 | CDC | 5/29/2023 | $54,005 |
| | 2023 | 2023 | GEISINGER CLINIC | 100 N Academy Ave | Danville | PA | 17822-9800 | MONTOUR | USA | U18DP006509 | Electronic Health Record-based Surveillance of Diabetes by Type in Young Adults in Pennsylvania | 00 | 4 | CDC | 5/29/2023 | $195,995 |
| | 2023 | 2023 | GEISINGER CLINIC | 100 N ACADEMY AVE | DANVILLE | PA | 17822-9800 | MONTOUR | USA | U01HL146188 | Collaborative Research to Explore Genetic Variation and Phenotypic Spectrum of Elastin and Related Genes | 001 | 4 | NIH | 4/10/2023 | $639,186 |
| | 2023 | 2023 | GEISINGER CLINIC | 100 N ACADEMY AVE | DANVILLE | PA | 17822-9800 | MONTOUR | USA | U01MH119705 | Leveraging rare genetic etiologies to advance knowledge and treatment of neuropsychiatric disorders | 000 | 5 | NIH | 3/20/2023 | $1,337,391 |
| | 2023 | 2023 | GEISINGER CLINIC | 100 N ACADEMY AVE | DANVILLE | PA | 17822-9800 | MONTOUR | USA | U01MH119705 | Leveraging rare genetic etiologies to advance knowledge and treatment of neuropsychiatric disorders | 000 | 5 | NIH | 3/20/2023 | $173,767 |
| | 2023 | 2023 | GEISINGER CLINIC | 100 N ACADEMY AVE | DANVILLE | PA | 17822-9800 | MONTOUR | USA | U01MH119705 | Leveraging rare genetic etiologies to advance knowledge and treatment of neuropsychiatric disorders | 000 | 5 | NIH | 3/20/2023 | $315,563 |
| | 2023 | 2023 | GEISINGER CLINIC | 100 N Academy Ave | Danville | PA | 17822-9800 | MONTOUR | USA | H7646012 | Ryan White Part C Outpatient EIS Program | 00 | 2 | HRSA | 3/15/2023 | $349,993 |
| | 2023 | 2023 | GEISINGER CLINIC | 100 N ACADEMY AVE | DANVILLE | PA | 17822-9800 | MONTOUR | USA | K01DA049903 | Understanding the role of community determinants in opioid use disorder and program implementation factors influencing patient adherence to opioid agonist therapy | 000 | 4 | NIH | 6/12/2023 | $162,032 |
| | 2023 | 2023 | GEISINGER CLINIC | 100 N ACADEMY AVE | DANVILLE | PA | 17822-9800 | MONTOUR | USA | R01HL159182 | Improving Risk Stratification in Familial Hypercholesterolemia (RISK-FH) | 000 | 2 | NIH | 6/20/2023 | $738,253 |
| | 2023 | 2023 | GEISINGER CLINIC | 100 N ACADEMY AVE | DANVILLE | PA | 17822-9800 | MONTOUR | USA | R33HL161775 | Collaborative Approach to Reach Everyone with Familial Hypercholesterolemia: CARE-FH | 000 | 2 | NIH | 2/2/2023 | $731,243 |
| | 2023 | 2023 | GEISINGER CLINIC | 100 N ACADEMY AVE | DANVILLE | PA | 17822-9800 | MONTOUR | USA | R01HD104938 | Characterizing the spectrum of genomic and phenotypic variation in cerebral palsy | 000 | 2 | NIH | 7/30/2023 | $680,237 |
| | 2023 | 2023 | GEISINGER CLINIC | 100 N ACADEMY AVE | DANVILLE | PA | 17822-9800 | MONTOUR | USA | R01HG011799 | Real-time genetic diagnosis at the point of care | 000 | 3 | NIH | 6/15/2023 | $921,082 |
| | 2023 | 2023 | GEISINGER CLINIC | 100 N ACADEMY AVE | DANVILLE | PA | 17822-9800 | MONTOUR | USA | H79TI084778 | Free2BMom | 000 | 2 | SAMHSA | 6/28/2023 | $523,545 |
| | 2023 | 2023 | GEISINGER CLINIC | 100 N ACADEMY AVE | DANVILLE | PA | 17822-9800 | MONTOUR | USA | R01HL141901 | A Precision Medicine Approach to Arrhythmogenic Cardiomyopathy | 002 | 5 | NIH | 3/6/2023 | $62,602 |
| | 2023 | 2023 | GEISINGER CLINIC | 100 N ACADEMY AVE | DANVILLE | PA | 17822-9800 | MONTOUR | USA | R01HL141901 | A Precision Medicine Approach to Arrhythmogenic Cardiomyopathy | 001 | 5 | NIH | 12/27/2022 | $563,407 |
| | 2023 | 2023 | GEISINGER CLINIC | 100 N ACADEMY AVE | DANVILLE | PA | 17822-9800 | MONTOUR | USA | U01CA240747 | Feasibility and Assessment of a Cascade Traceback Screening program - FACTS | 001 | 4 | NIH | 5/26/2023 | $658,560 |
| | 2023 | 2023 | GEISINGER CLINIC | 100 N ACADEMY AVE | DANVILLE | PA | 17822-9800 | MONTOUR | USA | UG1CA189847 | Geisinger Cancer Institute - NCI Community Oncology Research Program (NCORP) | 000 | 10 | NIH | 8/1/2023 | $1,554,577 |
| | 2023 | 2023 | GEISINGER CLINIC | 100 N ACADEMY AVE | DANVILLE | PA | 17822-9800 | MONTOUR | USA | R61DA059880 | Evaluation of a peer recovery support program adapted to target retention in clinic-based medication for opioid use disorder treatment | 000 | 1 | NIH | 9/21/2023 | $943,458 |
| | 2023 | 2023 | GEISINGER CLINIC | 100 N Academy Ave | Danville | PA | 17822-9800 | MONTOUR | USA | D5837570 | Residency Training in Primary Care | 01 | 4 | HRSA | 5/23/2023 | $47,619 |
|
